Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples